News and Comments

COULD AGENUS VACCINE FOR GLIOBLASTOMA BE ASSIGNED BREAKTHROUGH DESIGNATION?

  Tuesday, September 17, 2013

AGENUS (AGEN) has extraordinary news. A recent analysis from a Phase 2 trial in patients with newly diagnosed glioblastoma multiforme (GBM) treated with Prophage Series G-100 (HSPPC-96) in combination with the current standard of care (radiation and temozolomide) showed an almost 18 month median progression free survival (PFS), which represents a 160% increase versus current standard of care alone. The results confirm continuation of the positive trends from the Phase 2 HSPPC-96 newly diagnosed GBM trial first reported at the 81st American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in May 2013. More...

AGENUS OFFERS AN INVESTMENT OPPORTUNITY.

  Saturday, September 07, 2013

 More...


Recent Postings


Archive


Tags

Exelixis (EXEL) Array Pharmaceuticals (ARRY) Seattle Genetics (SGEN) Human Longevity (HLI) Endometrial Cancer Theravance Bio Pharma (TBPH) Tysabri ADVENTRIX (ANX) Anacor (ANAC) Sanofi (SNY) Elan (ELN) CompuGen (CGEN) Alnylam (ALNY) ABBVIE (ABBV) Gilead (GILD) Theravance (THRX) Biogen Idec (BIIB) Auspex (ASPX) TOKAI (TKAOI) KERYX (KERX) OSI (OSIP) C4 Therapeutics Agenus (AGEN) Intercept (ICPT) Idenix (IDIX) Genentech Velcade (bortezomib) GUARDIAN HEALTH Anadys (ANDS) ACADIA (ACAD) SERES THERAPEUTICS (MCRB) ImmunoGen (IMGN) JUNO (JUNO) Rapamune Bristol-Myers Squibb (BMY) Sequenom (SQNM) Biocryst (BCRX) Telaprevir Regeneron (REGN) Micromet (MITI) Sanofi (SNA) Editas (EDIT) Multiple Myeloma Intrexon (XON) Prosensa (RNA) ISIS (ISIS) Roche (ROCHE) GlaxoSmithKline (GSK) Trastuzumab-DM1 NANTKWEST (NK) Dendreon (DNDN) Incyte (INCY) KITE (KITE) Vitae Pharmaceuticals (VTAE) galapagos (GLPG) Alder Biopharmaceuticals (ALDR) ZALTRAP™ AERIE PHARMACEUTICALS Herceptin Aimmune Therapeutics (AIMT) Ionis (IONS) Ziofpharm (ZIOP) RenenxBio (RGNX) ARCA (ABIO) Jazz Pharmaceuticals (JAZZ) Onyx (ONXX) Vertex (VRTX) Agenus (AGEN Zerenex Sanofi-Aventis (SAN) Inovio (INO) REGULUS (RGLS) PTC Therapeutics (PTCT) BIOMARIN (BMRN) Xoma (XOMA) Cytokinetics (CYTK) Pluristem (PSTI) Benlysta (belimumab) Sangamo (SGMO) Sarepta (SRPT) Dynavax (DVAX) Merck (MRK) HALOZYME (HALO) Ariad (ARIA) Intermune (ITMN) Revlimid (lenolidamide) NEKTAR (NKTR)) Abbott Laboratories (ABT) SYNTA (SNTA) Illumina (ILMN) SUNESIS PHARMACEUTICALS (SNSS) Valeant Pharmaceuticals International (VRX) IDERA (IDRA) Human Genome Sciences (HGSI) Mirati Therapeutics (MRTX) Roche (RHHBY) VANDA (VNDA) Amgen (AMGN) Prolor Biotech (PBTH) Galena (GALE) Ridaforolimus